Establishing a system that replicates key pathological features of neurodegenerative diseases, tau aggregation and cell death, without requiring long-term, complex cell culture offers a significant advantage for the development of novel therapeutic drugs. This evidence concerns the gene MAPT and neurodegenerative disease.